FMP

FMP

Enter

ALNOV.PA - Novacyt S.A.

Financial Summary of Novacyt S.A.(ALNOV.PA), Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, contract desi

photo-url-https://financialmodelingprep.com/image-stock/ALNOV.PA.png

Novacyt S.A.

ALNOV.PA

EURONEXT

Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, contract design, and commercialization of diagnostic products for cancer and infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Lab21 Products segment develops, manufactures, and distributes a range of protein-based infectious disease in-vitro diagnostic device (IVD) products. The IT-IS International segment develops and manufactures PCR devices for the life sciences and food testing industry. It serves hospitals and corporates. The company was incorporated in 2006 and is based in Vélizy-Villacoublay, France.

0.731 EUR

0.021 (2.87%)

About

ceo

Mr. Lyn Dafydd Rees

sector

Healthcare

industry

Medical - Devices

website

https://www.novacyt.com

exchange

EURONEXT

Description

Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, contract design, and commercialization of diagnostic products for cancer and infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Lab21 Products segment develops, manufactures, and distributes a range of protein-based infectious disease in-vitro diagnostic device (IVD) products. The IT-IS International segme...

CIK

N/A

ISIN

FR0010397232

CUSIP

N/A

Address

13 Avenue Morane Saulnier

Phone

33 1 39 46 51 04

Country

FR

Employee

120

IPO Date

Oct 12, 2012

Summary

CIK

-

Exchange

EURONEXT

Industry

Medical - Devices

Sector

Healthcare

CUSIP

-

ISIN

FR0010397232

Country

FR

Price

0.73

Beta

-1.8

Volume Avg.

194.93k

Market Cap

51.63M

Shares

-

52-Week

0.42-0.995

DCF

1.09

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-1.74

P/B

-

Website

https://www.novacyt.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest ALNOV.PA News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep